Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis

Fig. 4

miR-196b-5p targeted downregulation of Socs3. A Binding sites of miR-196b-5p and Socs3; B Dual luciferase reporter gene; C Immunohistochemical staining for Socs3 expression; D Western blot for Socs3 expression. Compared with the NC group, ** P < 0.01, *** P < 0.001; compared with the LPS group, # P < 0.05; compared with the LPS + co-treatment group, $ P < 0.05. mimic represents mir-196b-5p mimic

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us